| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ephrin receptor activity | 9.02e-13 | 19 | 158 | 8 | GO:0005003 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | EPHB3 EPHB4 RIPK2 HIPK2 BAZ1B PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 9.40e-12 | 145 | 158 | 14 | GO:0004713 |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 1.05e-09 | 15 | 158 | 6 | GO:0005005 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.12e-09 | 65 | 158 | 9 | GO:0004714 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.38e-08 | 85 | 158 | 9 | GO:0019199 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 1.30e-07 | 7 | 158 | 4 | GO:0005004 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 7.80e-06 | 35 | 158 | 5 | GO:0015020 | |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB3 EPHB4 RIPK2 OBSCN HIPK2 BAZ1B PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 8.67e-05 | 600 | 158 | 15 | GO:0004672 |
| GeneOntologyMolecularFunction | interleukin-1 binding | 1.01e-04 | 12 | 158 | 3 | GO:0019966 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.86e-04 | 3 | 158 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | NACHT domain binding | 1.86e-04 | 3 | 158 | 2 | GO:0032089 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.47e-04 | 156 | 158 | 7 | GO:0019838 | |
| GeneOntologyMolecularFunction | nucleoside:sodium symporter activity | 3.69e-04 | 4 | 158 | 2 | GO:0005415 | |
| GeneOntologyMolecularFunction | nucleobase:monoatomic cation symporter activity | 3.69e-04 | 4 | 158 | 2 | GO:0015391 | |
| GeneOntologyMolecularFunction | pyrimidine- and adenosine-specific:sodium symporter activity | 3.69e-04 | 4 | 158 | 2 | GO:0015389 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCB7 DHX58 MYO5A MYO7B TWNK MORC4 ABCC6 ZRANB3 ACSL1 ACSM4 IQCA1 ABCC12 DHX35 DNAH6 | 3.83e-04 | 614 | 158 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 4.75e-04 | 46 | 158 | 4 | GO:0004715 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB3 EPHB4 RIPK2 OBSCN HIPK2 BAZ1B PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 5.20e-04 | 709 | 158 | 15 | GO:0016773 |
| GeneOntologyMolecularFunction | retinoid binding | 5.60e-04 | 48 | 158 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 6.06e-04 | 49 | 158 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | uridine transmembrane transporter activity | 9.14e-04 | 6 | 158 | 2 | GO:0015213 | |
| GeneOntologyMolecularFunction | kinase activity | EPHB3 EPHB4 RIPK2 OBSCN HIPK2 BAZ1B PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 1.11e-03 | 764 | 158 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | pyrimidine nucleobase transmembrane transporter activity | 1.27e-03 | 7 | 158 | 2 | GO:0005350 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 1.38e-03 | 28 | 158 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | pyrimidine nucleoside transmembrane transporter activity | 1.69e-03 | 8 | 158 | 2 | GO:0015214 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 2.55e-10 | 54 | 156 | 9 | GO:0048013 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 4.20e-06 | 5 | 156 | 3 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 8.35e-06 | 6 | 156 | 3 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 8.35e-06 | 6 | 156 | 3 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 8.35e-06 | 6 | 156 | 3 | GO:0051552 | |
| GeneOntologyBiologicalProcess | axon guidance | EPHB3 BOC PTK2 PTPRM IGSF9 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 1.14e-05 | 285 | 156 | 11 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | EPHB3 BOC PTK2 PTPRM IGSF9 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 1.18e-05 | 286 | 156 | 11 | GO:0097485 |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.21e-05 | 141 | 156 | 8 | GO:0006805 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.70e-05 | 21 | 156 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 4.13e-05 | 26 | 156 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 4.13e-05 | 26 | 156 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 4.53e-05 | 52 | 156 | 5 | GO:0008210 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 4.85e-05 | 171 | 156 | 8 | GO:0048593 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 4.90e-05 | 10 | 156 | 3 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 4.90e-05 | 10 | 156 | 3 | GO:0009804 | |
| GeneOntologyBiologicalProcess | dendrite development | EPHB3 GPR37 ITSN1 TSC2 NFATC4 ABI2 IGSF9 CAMSAP2 EPHA4 EPHA5 EPHB1 | 5.05e-05 | 335 | 156 | 11 | GO:0016358 |
| GeneOntologyBiologicalProcess | neuron projection fasciculation | 5.60e-05 | 28 | 156 | 4 | GO:0106030 | |
| GeneOntologyBiologicalProcess | axonal fasciculation | 5.60e-05 | 28 | 156 | 4 | GO:0007413 | |
| GeneOntologyBiologicalProcess | fasciculation of motor neuron axon | 5.68e-05 | 2 | 156 | 2 | GO:0097156 | |
| GeneOntologyBiologicalProcess | neuron recognition | 8.36e-05 | 59 | 156 | 5 | GO:0008038 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 1.00e-04 | 141 | 156 | 7 | GO:0060996 | |
| GeneOntologyBiologicalProcess | central nervous system neuron development | 1.07e-04 | 99 | 156 | 6 | GO:0021954 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 1.15e-04 | 13 | 156 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 1.54e-04 | 67 | 156 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 1.66e-04 | 204 | 156 | 8 | GO:0048592 | |
| GeneOntologyBiologicalProcess | fasciculation of sensory neuron axon | 1.70e-04 | 3 | 156 | 2 | GO:0097155 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | EPHB3 EPHB4 GP6 TSC2 PTK2 TXNIP ZNF106 NFATC4 EPHA2 ROS1 MMP14 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 1.77e-04 | 747 | 156 | 16 | GO:0007169 |
| GeneOntologyBiologicalProcess | cellular response to follicle-stimulating hormone stimulus | 1.81e-04 | 15 | 156 | 3 | GO:0071372 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | CYP3A5 UGT1A10 UGT1A8 UGT1A9 SLC28A3 ABCC6 GSTM4 ACSL1 TXNIP PTPRM MTHFR SLC28A2 PNP | 1.84e-04 | 525 | 156 | 13 | GO:0009410 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | EPHB3 EPHB4 GP6 RIPK2 TSC2 PTK2 EPHA2 BTNL2 ZC3H12D EGFLAM POLDIP2 MMP14 EPHA3 EPHA4 PNP EPHA5 EPHA8 FOXP3 | 2.32e-04 | 927 | 156 | 18 | GO:0030155 |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 2.94e-04 | 222 | 156 | 8 | GO:0071466 | |
| GeneOntologyBiologicalProcess | central nervous system neuron axonogenesis | 3.09e-04 | 43 | 156 | 4 | GO:0021955 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | EPHB3 EPHB4 ERVFC1 OBSCN HIPK2 TSC2 PPP1R15A NEB ST14 PTK2 CFHR4 PTPRM NFATC4 MTHFR SUPT6H EPHA2 NBEAL2 PHACTR4 RIPPLY1 MMP14 CNOT1 EPHA5 EPHB1 LARGE1 | 3.24e-04 | 1483 | 156 | 24 | GO:0048646 |
| GeneOntologyBiologicalProcess | positive regulation of GTP binding | 3.38e-04 | 4 | 156 | 2 | GO:1904426 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 3.52e-04 | 228 | 156 | 8 | GO:0046777 | |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 3.74e-04 | 81 | 156 | 5 | GO:0060997 | |
| GeneOntologyBiologicalProcess | xenobiotic transmembrane transport | 3.76e-04 | 19 | 156 | 3 | GO:0006855 | |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB3 MYO5A ITSN1 TSC2 PTK2 NFATC4 ABI2 EPHA2 IGSF9 MARVELD2 POLDIP2 MMP14 CNTN2 EPHA3 EPHA4 EPHA5 EPHB1 LARGE1 | 4.21e-04 | 974 | 156 | 18 | GO:0034330 |
| GeneOntologyBiologicalProcess | hormone catabolic process | 5.11e-04 | 21 | 156 | 3 | GO:0042447 | |
| GeneOntologyBiologicalProcess | response to follicle-stimulating hormone | 5.11e-04 | 21 | 156 | 3 | GO:0032354 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | PDE4C BAAT OGDH NDUFS1 ABCC6 CFHR4 ACSL1 ACSM4 EPHA2 MFSD8 SDHB PNP | 5.34e-04 | 512 | 156 | 12 | GO:0009150 |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 5.60e-04 | 5 | 156 | 2 | GO:0052696 | |
| GeneOntologyBiologicalProcess | purine nucleoside transmembrane transport | 5.60e-04 | 5 | 156 | 2 | GO:0015860 | |
| GeneOntologyBiologicalProcess | cellular response to gonadotropin stimulus | 5.88e-04 | 22 | 156 | 3 | GO:0071371 | |
| GeneOntologyBiologicalProcess | synapse organization | EPHB3 MYO5A ITSN1 TSC2 PTK2 NFATC4 ABI2 IGSF9 CNTN2 EPHA3 EPHA4 EPHA5 EPHB1 LARGE1 | 7.21e-04 | 685 | 156 | 14 | GO:0050808 |
| GeneOntologyBiologicalProcess | pigment metabolic process | 7.41e-04 | 94 | 156 | 5 | GO:0042440 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | PDE4C BAAT OGDH NDUFS1 ABCC6 CFHR4 ACSL1 ACSM4 EPHA2 MFSD8 SDHB PNP | 7.59e-04 | 533 | 156 | 12 | GO:0009259 |
| GeneOntologyBiologicalProcess | retinal ganglion cell axon guidance | 7.64e-04 | 24 | 156 | 3 | GO:0031290 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 5.40e-14 | 14 | 155 | 8 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 5.40e-14 | 14 | 155 | 8 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 5.40e-14 | 14 | 155 | 8 | IPR001426 | |
| Domain | EphA2_TM | 5.40e-14 | 14 | 155 | 8 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 5.40e-14 | 14 | 155 | 8 | IPR001090 | |
| Domain | Eph_TM | 5.40e-14 | 14 | 155 | 8 | IPR027936 | |
| Domain | EPH_lbd | 5.40e-14 | 14 | 155 | 8 | SM00615 | |
| Domain | Ephrin_lbd | 5.40e-14 | 14 | 155 | 8 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 5.40e-14 | 14 | 155 | 8 | IPR016257 | |
| Domain | EPH_LBD | 5.40e-14 | 14 | 155 | 8 | PS51550 | |
| Domain | Ephrin_rec_like | 2.69e-13 | 25 | 155 | 9 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 2.69e-13 | 25 | 155 | 9 | IPR011641 | |
| Domain | fn3 | EPHB3 EPHB4 BOC OBSCN PTPRM EPHA2 IGSF9 ROS1 EGFLAM CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 5.87e-12 | 162 | 155 | 15 | PF00041 |
| Domain | PROTEIN_KINASE_TYR | EPHB3 EPHB4 OBSCN PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 2.70e-11 | 97 | 155 | 12 | PS00109 |
| Domain | Tyr_kinase_AS | EPHB3 EPHB4 OBSCN PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 2.70e-11 | 97 | 155 | 12 | IPR008266 |
| Domain | FN3 | EPHB3 EPHB4 BOC OBSCN PTPRM EPHA2 IGSF9 ROS1 EGFLAM CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 3.98e-11 | 185 | 155 | 15 | SM00060 |
| Domain | FN3 | EPHB3 EPHB4 BOC OBSCN PTPRM EPHA2 IGSF9 ROS1 EGFLAM CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 1.12e-10 | 199 | 155 | 15 | PS50853 |
| Domain | Tyr_kinase_cat_dom | EPHB3 EPHB4 PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 1.66e-10 | 88 | 155 | 11 | IPR020635 |
| Domain | TyrKc | EPHB3 EPHB4 PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 1.66e-10 | 88 | 155 | 11 | SM00219 |
| Domain | FN3_dom | EPHB3 EPHB4 BOC OBSCN PTPRM EPHA2 IGSF9 ROS1 EGFLAM CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 2.24e-10 | 209 | 155 | 15 | IPR003961 |
| Domain | Pkinase_Tyr | EPHB3 EPHB4 RIPK2 PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 7.89e-10 | 129 | 155 | 12 | PF07714 |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | EPHB3 EPHB4 RIPK2 PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 1.72e-09 | 138 | 155 | 12 | IPR001245 |
| Domain | Galactose-bd-like | 5.76e-09 | 94 | 155 | 10 | IPR008979 | |
| Domain | - | 9.13e-09 | 73 | 155 | 9 | 2.60.120.260 | |
| Domain | SAM | 6.88e-07 | 88 | 155 | 8 | SM00454 | |
| Domain | SAM_DOMAIN | 1.24e-06 | 95 | 155 | 8 | PS50105 | |
| Domain | Ephrin_rec_like | 1.44e-06 | 11 | 155 | 4 | PF07699 | |
| Domain | SAM | 1.45e-06 | 97 | 155 | 8 | IPR001660 | |
| Domain | - | 2.85e-06 | 106 | 155 | 8 | 1.10.150.50 | |
| Domain | SAM/pointed | 5.96e-06 | 117 | 155 | 8 | IPR013761 | |
| Domain | Ig-like_fold | EPHB3 EPHB4 BOC GP6 OBSCN IGHA1 PTPRM NFATC4 EPHA2 BTNL2 IGSF9 ROS1 EGFLAM CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 6.41e-06 | 706 | 155 | 19 | IPR013783 |
| Domain | - | EPHB3 EPHB4 BOC GP6 OBSCN PTPRM NFATC4 EPHA2 BTNL2 IGSF9 ROS1 EGFLAM CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 1.02e-05 | 663 | 155 | 18 | 2.60.40.10 |
| Domain | Protein_kinase_ATP_BS | EPHB3 EPHB4 OBSCN HIPK2 PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 1.71e-05 | 379 | 155 | 13 | IPR017441 |
| Domain | SAM_1 | 2.12e-05 | 68 | 155 | 6 | PF00536 | |
| Domain | PROTEIN_KINASE_ATP | EPHB3 EPHB4 RIPK2 OBSCN HIPK2 PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 2.97e-05 | 459 | 155 | 14 | PS00107 |
| Domain | MYTH4 | 4.54e-05 | 9 | 155 | 3 | PS51016 | |
| Domain | MyTH4 | 4.54e-05 | 9 | 155 | 3 | SM00139 | |
| Domain | MyTH4_dom | 4.54e-05 | 9 | 155 | 3 | IPR000857 | |
| Domain | MyTH4 | 4.54e-05 | 9 | 155 | 3 | PF00784 | |
| Domain | Prot_kinase_dom | EPHB3 EPHB4 RIPK2 OBSCN HIPK2 PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 5.88e-05 | 489 | 155 | 14 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | EPHB3 EPHB4 RIPK2 OBSCN HIPK2 PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 6.42e-05 | 493 | 155 | 14 | PS50011 |
| Domain | Kinase-like_dom | EPHB3 EPHB4 RIPK2 OBSCN HIPK2 PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 1.74e-04 | 542 | 155 | 14 | IPR011009 |
| Domain | C_nuclsd_transpt | 2.04e-04 | 3 | 155 | 2 | IPR008276 | |
| Domain | CNT_C_dom | 2.04e-04 | 3 | 155 | 2 | IPR011657 | |
| Domain | C_nuclsd_transpt_met_bac | 2.04e-04 | 3 | 155 | 2 | IPR018270 | |
| Domain | Gate_dom | 2.04e-04 | 3 | 155 | 2 | IPR011642 | |
| Domain | Nucleos_tra2_N | 2.04e-04 | 3 | 155 | 2 | PF01773 | |
| Domain | Nucleos_tra2_C | 2.04e-04 | 3 | 155 | 2 | PF07662 | |
| Domain | Gate | 2.04e-04 | 3 | 155 | 2 | PF07670 | |
| Domain | CNT_N_dom | 2.04e-04 | 3 | 155 | 2 | IPR002668 | |
| Domain | InsP3_rcpt-bd | 2.04e-04 | 3 | 155 | 2 | IPR000493 | |
| Domain | Growth_fac_rcpt_ | 3.28e-04 | 156 | 155 | 7 | IPR009030 | |
| Domain | UDPGT | 6.68e-04 | 21 | 155 | 3 | PF00201 | |
| Domain | UDPGT | 6.68e-04 | 21 | 155 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 6.68e-04 | 21 | 155 | 3 | IPR002213 | |
| Domain | 2Fe2S_fd_BS | 6.73e-04 | 5 | 155 | 2 | IPR006058 | |
| Domain | 2FE2S_FER_1 | 6.73e-04 | 5 | 155 | 2 | PS00197 | |
| Domain | IQ_motif_EF-hand-BS | 9.20e-04 | 90 | 155 | 5 | IPR000048 | |
| Domain | ABC_membrane | 9.98e-04 | 24 | 155 | 3 | PF00664 | |
| Domain | RIH_assoc-dom | 1.00e-03 | 6 | 155 | 2 | IPR013662 | |
| Domain | 2FE2S_FER_2 | 1.00e-03 | 6 | 155 | 2 | PS51085 | |
| Domain | 2Fe-2S_ferredoxin-type | 1.00e-03 | 6 | 155 | 2 | IPR001041 | |
| Domain | Ins145_P3_rec | 1.00e-03 | 6 | 155 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.00e-03 | 6 | 155 | 2 | PF08454 | |
| Domain | RIH_dom | 1.00e-03 | 6 | 155 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.00e-03 | 6 | 155 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.00e-03 | 6 | 155 | 2 | IPR015925 | |
| Domain | Fer2 | 1.00e-03 | 6 | 155 | 2 | PF00111 | |
| Domain | - | 1.00e-03 | 6 | 155 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.00e-03 | 6 | 155 | 2 | PF01365 | |
| Domain | IQ | 1.07e-03 | 93 | 155 | 5 | PS50096 | |
| Domain | LIPASE_SER | 1.27e-03 | 26 | 155 | 3 | PS00120 | |
| Domain | zf-CW | 1.40e-03 | 7 | 155 | 2 | PF07496 | |
| Domain | ZF_CW | 1.40e-03 | 7 | 155 | 2 | PS51050 | |
| Domain | Znf_CW | 1.40e-03 | 7 | 155 | 2 | IPR011124 | |
| Domain | DNA_methylase_N6_adenine_CS | 1.40e-03 | 7 | 155 | 2 | IPR002052 | |
| Domain | ABC_TM1F | 1.58e-03 | 28 | 155 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 1.58e-03 | 28 | 155 | 3 | IPR011527 | |
| Domain | EGF_2 | 1.69e-03 | 265 | 155 | 8 | PS01186 | |
| Domain | N6_MTASE | 1.85e-03 | 8 | 155 | 2 | PS00092 | |
| Domain | SH3 | 2.20e-03 | 216 | 155 | 7 | SM00326 | |
| Domain | SH3 | 2.20e-03 | 216 | 155 | 7 | PS50002 | |
| Domain | ConA-like_dom | 2.38e-03 | 219 | 155 | 7 | IPR013320 | |
| Domain | SH3_domain | 2.44e-03 | 220 | 155 | 7 | IPR001452 | |
| Domain | MIR | 2.95e-03 | 10 | 155 | 2 | PF02815 | |
| Domain | Lipase/vitellogenin | 2.95e-03 | 10 | 155 | 2 | IPR013818 | |
| Domain | MIR_motif | 2.95e-03 | 10 | 155 | 2 | IPR016093 | |
| Domain | TAG_lipase | 2.95e-03 | 10 | 155 | 2 | IPR000734 | |
| Domain | Lipase | 2.95e-03 | 10 | 155 | 2 | PF00151 | |
| Domain | Lipase_N | 2.95e-03 | 10 | 155 | 2 | IPR033906 | |
| Domain | MIR | 2.95e-03 | 10 | 155 | 2 | PS50919 | |
| Domain | MIR | 2.95e-03 | 10 | 155 | 2 | SM00472 | |
| Domain | Lipase_LIPH | 2.95e-03 | 10 | 155 | 2 | IPR016272 | |
| Domain | Myosin_head_motor_dom | 3.82e-03 | 38 | 155 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.82e-03 | 38 | 155 | 3 | PS51456 | |
| Domain | Myosin_head | 3.82e-03 | 38 | 155 | 3 | PF00063 | |
| Domain | MYSc | 3.82e-03 | 38 | 155 | 3 | SM00242 | |
| Domain | IQ | 4.63e-03 | 81 | 155 | 4 | SM00015 | |
| Domain | PRY | 5.08e-03 | 42 | 155 | 3 | PF13765 | |
| Domain | ABC_transporter_CS | 5.08e-03 | 42 | 155 | 3 | IPR017871 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 4.65e-09 | 92 | 118 | 10 | M27201 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 8.95e-09 | 51 | 118 | 8 | M27311 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 6.43e-08 | 65 | 118 | 8 | MM14911 | |
| Pathway | KEGG_AXON_GUIDANCE | 1.22e-07 | 129 | 118 | 10 | M5539 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 3.36e-07 | 34 | 118 | 6 | MM15025 | |
| Pathway | REACTOME_DRUG_ADME | CYP3A5 UGT1A10 UGT1A8 UGT2A2 UGT1A9 SLC28A3 ACSM4 SLC28A2 PNP | 6.64e-07 | 119 | 118 | 9 | MM15692 |
| Pathway | REACTOME_ASPIRIN_ADME | 1.89e-06 | 45 | 118 | 6 | MM15694 | |
| Pathway | REACTOME_DRUG_ADME | 3.57e-06 | 109 | 118 | 8 | M45012 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 3.82e-06 | 29 | 118 | 5 | M27309 | |
| Pathway | PID_EPHA_FWDPATHWAY | 8.65e-06 | 34 | 118 | 5 | M177 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.33e-05 | 37 | 118 | 5 | MM15022 | |
| Pathway | PID_EPHB_FWD_PATHWAY | 1.96e-05 | 40 | 118 | 5 | M62 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 2.51e-05 | 42 | 118 | 5 | M27308 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 4.36e-05 | 24 | 118 | 4 | M46445 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.36e-05 | 24 | 118 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 5.15e-05 | 25 | 118 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 5.15e-05 | 25 | 118 | 4 | MM15820 | |
| Pathway | WP_GLUCURONIDATION | 6.05e-05 | 26 | 118 | 4 | M39404 | |
| Pathway | REACTOME_RIBAVIRIN_ADME | 8.98e-05 | 11 | 118 | 3 | M46429 | |
| Pathway | REACTOME_RIBAVIRIN_ADME | 1.19e-04 | 12 | 118 | 3 | MM16638 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 1.19e-04 | 12 | 118 | 3 | M39611 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 1.95e-04 | 14 | 118 | 3 | M39328 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.75e-04 | 107 | 118 | 6 | MM14595 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 2.96e-04 | 70 | 118 | 5 | M16794 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 3.04e-04 | 109 | 118 | 6 | M18788 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EPHB3 EPHB4 COL9A1 ITSN1 RPS9 PTK2 PSME4 EPHA2 CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 3.16e-04 | 575 | 118 | 14 | M29853 |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.38e-04 | 72 | 118 | 5 | M9257 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.44e-04 | 261 | 118 | 9 | MM15676 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 4.26e-04 | 18 | 118 | 3 | MM15023 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 4.26e-04 | 18 | 118 | 3 | MM15024 | |
| Pathway | REACTOME_ASPIRIN_ADME | 4.89e-04 | 44 | 118 | 4 | M45014 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 5.02e-04 | 19 | 118 | 3 | M27310 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 6.81e-04 | 21 | 118 | 3 | M39631 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 6.83e-04 | 5 | 118 | 2 | M49000 | |
| Pathway | WP_ESTROGEN_METABOLISM | 7.84e-04 | 22 | 118 | 3 | MM15888 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 8.61e-04 | 51 | 118 | 4 | M17726 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 1.02e-03 | 6 | 118 | 2 | M47960 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.14e-03 | 55 | 118 | 4 | M14933 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.15e-03 | 25 | 118 | 3 | M605 | |
| Pubmed | 1.36e-15 | 9 | 160 | 7 | 11403717 | ||
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 3.95e-15 | 17 | 160 | 8 | 12217323 | |
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 1.22e-14 | 19 | 160 | 8 | 12684176 | |
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 2.02e-14 | 20 | 160 | 8 | 11256076 | |
| Pubmed | 2.02e-14 | 20 | 160 | 8 | 10207129 | ||
| Pubmed | 2.02e-14 | 20 | 160 | 8 | 9530499 | ||
| Pubmed | 2.02e-14 | 20 | 160 | 8 | 9576626 | ||
| Pubmed | 3.25e-14 | 21 | 160 | 8 | 9267020 | ||
| Pubmed | 3.25e-14 | 21 | 160 | 8 | 11128993 | ||
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 3.25e-14 | 21 | 160 | 8 | 10495276 | |
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 3.25e-14 | 21 | 160 | 8 | 20112066 | |
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 3.25e-14 | 21 | 160 | 8 | 10730216 | |
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 1.16e-13 | 24 | 160 | 8 | 16446123 | |
| Pubmed | 1.28e-13 | 14 | 160 | 7 | 26941654 | ||
| Pubmed | EPHB3 EPHB4 PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 1.67e-13 | 83 | 160 | 11 | 11114734 | |
| Pubmed | Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling. | 8.81e-12 | 23 | 160 | 7 | 19542359 | |
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 1.74e-11 | 42 | 160 | 8 | 11439183 | |
| Pubmed | 9.05e-11 | 51 | 160 | 8 | 19769959 | ||
| Pubmed | 2.40e-10 | 9 | 160 | 5 | 33253166 | ||
| Pubmed | 4.79e-10 | 10 | 160 | 5 | 25073978 | ||
| Pubmed | EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes. | 4.79e-10 | 10 | 160 | 5 | 16547242 | |
| Pubmed | 8.74e-10 | 11 | 160 | 5 | 22171039 | ||
| Pubmed | 8.74e-10 | 11 | 160 | 5 | 15517401 | ||
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 1.42e-09 | 25 | 160 | 6 | 15254900 | |
| Pubmed | Ephrin/ephrin receptor expression during early stages of mouse inner ear development. | 1.49e-09 | 12 | 160 | 5 | 21465626 | |
| Pubmed | EphrinA-EphA receptor interactions in mouse spinal neurulation: implications for neural fold fusion. | 1.49e-09 | 12 | 160 | 5 | 19247962 | |
| Pubmed | Eph receptors are involved in the activity-dependent synaptic wiring in the mouse cerebellar cortex. | 2.15e-09 | 5 | 160 | 4 | 21559471 | |
| Pubmed | Eph-ephrin A system regulates murine blastocyst attachment and spreading. | 2.42e-09 | 13 | 160 | 5 | 17039519 | |
| Pubmed | 2.42e-09 | 13 | 160 | 5 | 12528186 | ||
| Pubmed | Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. | 1.15e-08 | 17 | 160 | 5 | 12971893 | |
| Pubmed | 1.49e-08 | 7 | 160 | 4 | 27514509 | ||
| Pubmed | 2.91e-08 | 40 | 160 | 6 | 30898150 | ||
| Pubmed | Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions. | 6.09e-08 | 23 | 160 | 5 | 25480914 | |
| Pubmed | 8.87e-08 | 10 | 160 | 4 | 28197551 | ||
| Pubmed | EphB signaling regulates target innervation in the developing and deafferented auditory brainstem. | 8.87e-08 | 10 | 160 | 4 | 22021100 | |
| Pubmed | EphB2 guides axons at the midline and is necessary for normal vestibular function. | 8.87e-08 | 10 | 160 | 4 | 10839360 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 8152808 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 7609620 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 12847094 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 29519853 | ||
| Pubmed | 1.39e-07 | 11 | 160 | 4 | 10559410 | ||
| Pubmed | 2.99e-07 | 13 | 160 | 4 | 16421308 | ||
| Pubmed | EPHB4 ABCB7 MYO5A ITSN1 BAZ1B TWNK OGDH NDUFS1 ITPR1 ITPR2 MRPS7 GANAB FAM171A2 SUPT6H EPHA2 PHACTR4 CCSER2 MARVELD2 POLDIP2 SNTB1 SOAT1 SDHB PNP | 3.64e-07 | 1487 | 160 | 23 | 33957083 | |
| Pubmed | LERK-7: a ligand of the Eph-related kinases is developmentally regulated in the brain. | 3.81e-07 | 4 | 160 | 3 | 9245480 | |
| Pubmed | A role for the EphA family in the topographic targeting of vomeronasal axons. | 4.17e-07 | 14 | 160 | 4 | 11222144 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 4.17e-07 | 14 | 160 | 4 | 14672974 | |
| Pubmed | 5.66e-07 | 15 | 160 | 4 | 36028553 | ||
| Pubmed | 6.24e-07 | 66 | 160 | 6 | 19898482 | ||
| Pubmed | 7.52e-07 | 16 | 160 | 4 | 8755474 | ||
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 21935409 | ||
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 19949912 | ||
| Pubmed | The ephrin signaling pathway regulates morphology and adhesion of mouse granulosa cells in vitro. | 9.49e-07 | 5 | 160 | 3 | 23242526 | |
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 15057901 | ||
| Pubmed | Embryonic stem cells express multiple Eph-subfamily receptor tyrosine kinases. | 9.49e-07 | 5 | 160 | 3 | 8552593 | |
| Pubmed | 1.24e-06 | 117 | 160 | 7 | 17145500 | ||
| Pubmed | Role for ephrinB2 in postnatal lung alveolar development and elastic matrix integrity. | 1.26e-06 | 18 | 160 | 4 | 18651661 | |
| Pubmed | 1.34e-06 | 75 | 160 | 6 | 15951569 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 32527940 | ||
| Pubmed | Area specificity and topography of thalamocortical projections are controlled by ephrin/Eph genes. | 1.89e-06 | 6 | 160 | 3 | 12895420 | |
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 15996548 | ||
| Pubmed | Distribution of EphB receptors and ephrin-B1 in the developing vertebrate spinal cord. | 1.89e-06 | 6 | 160 | 3 | 16786562 | |
| Pubmed | Ephrin-B3 reverse signaling through Grb4 and cytoskeletal regulators mediates axon pruning. | 1.89e-06 | 6 | 160 | 3 | 19182796 | |
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 20297805 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 7973638 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 3.30e-06 | 7 | 160 | 3 | 8467709 | |
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 8464825 | ||
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 8954633 | ||
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 7947319 | ||
| Pubmed | 3.57e-06 | 23 | 160 | 4 | 19571816 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 4.16e-06 | 91 | 160 | 6 | 28558017 | |
| Pubmed | Mistargeting hippocampal axons by expression of a truncated Eph receptor. | 5.26e-06 | 8 | 160 | 3 | 12124402 | |
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 15145949 | ||
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 20610558 | ||
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 18052087 | ||
| Pubmed | Profiling Eph receptor expression in cells and tissues: a targeted mass spectrometry approach. | 5.26e-06 | 8 | 160 | 3 | 22568954 | |
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 17179145 | ||
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 17884558 | ||
| Pubmed | Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2. | 5.26e-06 | 8 | 160 | 3 | 14988728 | |
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 22511988 | ||
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 10704386 | ||
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 7.87e-06 | 9 | 160 | 3 | 20732626 | |
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 23109900 | ||
| Pubmed | Topographic guidance labels in a sensory projection to the forebrain. | 7.87e-06 | 9 | 160 | 3 | 9883724 | |
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 18713744 | ||
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 11580899 | ||
| Pubmed | 1.12e-05 | 10 | 160 | 3 | 23642732 | ||
| Pubmed | 1.12e-05 | 10 | 160 | 3 | 11465080 | ||
| Pubmed | 1.12e-05 | 10 | 160 | 3 | 25923646 | ||
| Pubmed | Quantitative assessment of computational models for retinotopic map formation. | 1.12e-05 | 10 | 160 | 3 | 25367067 | |
| Pubmed | HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia. | 1.12e-05 | 10 | 160 | 3 | 17304517 | |
| Pubmed | 1.12e-05 | 10 | 160 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 1.12e-05 | 10 | 160 | 3 | 22558097 | |
| Pubmed | A2M TUT4 IARS1 BAZ1B ITPR1 TRIM16 ESYT3 COG1 SUPT6H IRAG2 ROS1 TFB2M PLEKHH2 WWC1 | 1.12e-05 | 754 | 160 | 14 | 35906200 | |
| Pubmed | 1.53e-05 | 11 | 160 | 3 | 20824138 | ||
| Pubmed | Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice. | 1.53e-05 | 11 | 160 | 3 | 24550361 | |
| Pubmed | 1.53e-05 | 11 | 160 | 3 | 26644518 | ||
| Pubmed | Compensatory Actions of Ldb Adaptor Proteins During Corticospinal Motor Neuron Differentiation. | 1.59e-05 | 33 | 160 | 4 | 26830346 | |
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 1281307 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.04e-05 | 12 | 160 | 3 | 20308471 | |
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 19419973 | ||
| Interaction | EFNA5 interactions | 9.09e-07 | 68 | 155 | 7 | int:EFNA5 | |
| Interaction | EFNA1 interactions | 1.48e-05 | 103 | 155 | 7 | int:EFNA1 | |
| Interaction | EFNB2 interactions | 1.51e-05 | 143 | 155 | 8 | int:EFNB2 | |
| Cytoband | 2q37 | 1.74e-04 | 31 | 160 | 3 | 2q37 | |
| Cytoband | Xq22.3 | 2.10e-04 | 33 | 160 | 3 | Xq22.3 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 5.27e-15 | 14 | 113 | 8 | 1095 | |
| GeneFamily | Fibronectin type III domain containing | EPHB3 EPHB4 BOC OBSCN PTPRM EPHA2 IGSF9 ROS1 EGFLAM CNTN2 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 7.05e-14 | 160 | 113 | 15 | 555 |
| GeneFamily | Sterile alpha motif domain containing | 7.69e-08 | 88 | 113 | 8 | 760 | |
| GeneFamily | UDP glucuronosyltransferases | 4.54e-05 | 32 | 113 | 4 | 363 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 1.16e-04 | 3 | 113 | 2 | 297 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.67e-04 | 50 | 113 | 4 | 1293 | |
| GeneFamily | Zinc fingers CW-type | 7.97e-04 | 7 | 113 | 2 | 96 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 9.66e-04 | 181 | 113 | 6 | 694 | |
| GeneFamily | ATP binding cassette subfamily C | 2.89e-03 | 13 | 113 | 2 | 807 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.41e-03 | 161 | 113 | 5 | 593 | |
| GeneFamily | DEAH-box helicases | 4.39e-03 | 16 | 113 | 2 | 500 | |
| GeneFamily | T-boxes | 5.55e-03 | 18 | 113 | 2 | 766 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-09 | 184 | 158 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-09 | 184 | 158 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-09 | 184 | 158 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-06 | 171 | 158 | 7 | 9e00c8191ca9d52151a49baf39f8581cb176fb76 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-06 | 171 | 158 | 7 | f648789e6aefe508bb748401bf9b3cd830fb0ddf | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-06 | 171 | 158 | 7 | 6a489a75eeab2a2d48d604682e93599c20a945fe | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.77e-06 | 172 | 158 | 7 | 92e76cbf4807704790f42cf2507e92f85cd3bc92 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.88e-06 | 173 | 158 | 7 | ee972d9cc68755926512fd3bbe1267098c67cd94 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-06 | 175 | 158 | 7 | 06af6629766e2054e6995e8cdb3907658fec49d3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-06 | 176 | 158 | 7 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.61e-06 | 179 | 158 | 7 | b35a7f8115c997c390201da01d7cb10b10769aec | |
| ToppCell | Neuronal-Excitatory-eB(RORB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.47e-06 | 200 | 158 | 7 | 51265e30f1138fd79733001d0db759f3dab0aaeb | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 152 | 158 | 6 | 77b319f594d5e4df29034bbf69c7490076f89dd3 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 156 | 158 | 6 | d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4|Lung / Manually curated celltypes from each tissue | 2.48e-05 | 162 | 158 | 6 | 91cc14aec8d580cf97a1929bc1acb00fcbcdb57a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.59e-05 | 173 | 158 | 6 | 8335b77f730ed43fc348a005566e73a103c6774b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.71e-05 | 174 | 158 | 6 | 2947e5906b172d149412fa4e77476fce4ea695d2 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 176 | 158 | 6 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 176 | 158 | 6 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.08e-05 | 177 | 158 | 6 | 7e799333307448c6a94d1f33dbc59c543336f45e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.48e-05 | 180 | 158 | 6 | b7513b9816a9cb9f3caaddb2a9fed0be1c7f9805 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.48e-05 | 180 | 158 | 6 | f96c5be4705e3d338c0393d2885ac8d5beccd6fd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 182 | 158 | 6 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.91e-05 | 183 | 158 | 6 | 01664fce6b70a02c9d39d747b6a6aabc86d57bc2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.06e-05 | 184 | 158 | 6 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-05 | 184 | 158 | 6 | 9cc5c588f7c6631b3fb8a522214a09ca32947e72 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.37e-05 | 186 | 158 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.37e-05 | 186 | 158 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.53e-05 | 187 | 158 | 6 | 689b3cc76f1e04bd35a7d3ce19e9f08744a7835b | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.53e-05 | 187 | 158 | 6 | 4527d6426f2c4397e47f12439a13a8c14fd2aab2 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.53e-05 | 187 | 158 | 6 | 6820bfbe552ea5e62cfe699687b051a17d9fda61 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.70e-05 | 188 | 158 | 6 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.70e-05 | 188 | 158 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-05 | 189 | 158 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-05 | 190 | 158 | 6 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.04e-05 | 190 | 158 | 6 | 441770ce7b3c81f36f5b15b8e51794f736462457 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 191 | 158 | 6 | abdd93b2313e635f75a750d051a6a01ddc4e2df9 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-05 | 192 | 158 | 6 | 44cb225392c8d07150955ecf203fbdf6021c9790 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.98e-05 | 195 | 158 | 6 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.98e-05 | 195 | 158 | 6 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 196 | 158 | 6 | 22fcfb713f402ebbd43b2822f0fd919cdbfba6e4 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.18e-05 | 196 | 158 | 6 | de43dd0697e1daf4d50800957cf0b27b54a7a333 | |
| ToppCell | Thalamus-Macroglia-ASTROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.18e-05 | 121 | 158 | 5 | c3a4dfd19b7e8654e859df605d55155b530ad009 | |
| ToppCell | Thalamus-Macroglia-ASTROCYTE-Gja1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.18e-05 | 121 | 158 | 5 | c3efd44bd01c12ef8c7ce4cc351af1540b70a63c | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.38e-05 | 197 | 158 | 6 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | 3'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.59e-05 | 198 | 158 | 6 | 7ad7726fc405806b1d7824f58548073ea5e0c70b | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.59e-05 | 198 | 158 | 6 | 1fbec311f2c987ca90a023a5989128c05aa12d5c | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.59e-05 | 198 | 158 | 6 | ceede961ad9af6a3159db7efaa5087bf38aafc2d | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.59e-05 | 198 | 158 | 6 | 4f26a60e99f42343e5af7221723e108a1a1b7827 | |
| ToppCell | Transverse-T_cell-Tfh|Transverse / Region, Cell class and subclass | 7.80e-05 | 199 | 158 | 6 | cbef8f95edf2e86e16c448a76068d7ed8f6b7748 | |
| ToppCell | Transverse-(1)_T_cell-(16)_Tfh|Transverse / shred on region, Cell_type, and subtype | 7.80e-05 | 199 | 158 | 6 | aa31e26d48066f865ca33251a33a28934c0a7a44 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.80e-05 | 199 | 158 | 6 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.80e-05 | 199 | 158 | 6 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 158 | 6 | bdda59ffa0496256dd7a5937e88baac5c2a656c3 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 158 | 6 | dff0be30309b6f5f8757b0378ef05ce97f75dbe8 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B---L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 158 | 6 | c3474e8a03ec4869fd3636a5559d36dd9c5fd414 | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 158 | 6 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-05 | 200 | 158 | 6 | 3e13c9a4ba99a7dfbf738b0fb63fb54b4dee5897 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 158 | 6 | 1a3d29a580d1b405a74869a1da3e818c581fc559 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.02e-05 | 200 | 158 | 6 | 69707f9576d326a06faac49701ef5cd632e760f6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial-Proteoglycan-expressing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.02e-05 | 200 | 158 | 6 | f94381d0a3b5b81cdbb13b75fc0e4910cbd70382 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E---L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 158 | 6 | 6f9ed8fe9cda91185c3a1a675353e11b8fec6ef1 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 158 | 6 | 5c0c09e7b84fed053b299848bdff63ab842a445c | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 158 | 6 | 86705dfc05b3e1576543b93883c88fb55b742855 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 158 | 6 | db194b4f524fd008b3c5b4b6014b436190a1b87a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-05 | 200 | 158 | 6 | 73bfdf068a8ecbefc1e6afe9686df73658ee042f | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.12e-04 | 70 | 158 | 4 | 8d6bdf2e773e894a0db39fdff1fafc2474e03fcf | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.96e-04 | 32 | 158 | 3 | b2d87153b4aefefd7b5e31ea67aa43e5f599e734 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.96e-04 | 32 | 158 | 3 | f5bcaacbddfb85439ebf5908762bf39cb72b727c | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.03e-04 | 151 | 158 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.03e-04 | 151 | 158 | 5 | e1ffd99001b6a5b795f3367882a9355955c0e569 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-04 | 151 | 158 | 5 | 5d64655b6b09cc0a6d44629a31048b787a0916c5 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-04 | 156 | 158 | 5 | fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.36e-04 | 156 | 158 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-04 | 157 | 158 | 5 | f6210be2362d833c6d869ff921188bfc85dda11d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-04 | 157 | 158 | 5 | 43a6b423fd70479822a564ff4225a1e4951ae5ed | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-04 | 158 | 158 | 5 | 0c9bb7f8d080a052ca71701544a076c6c2ea67cd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-04 | 158 | 158 | 5 | cebb58878b6945074bc1c7d5848d842da5dcbae1 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 2.50e-04 | 158 | 158 | 5 | ab05f6d7968ccd6d3826cd71b763dbedc83822c3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-04 | 158 | 158 | 5 | 2cfa6dd36c8ae534cf1dd49366d4b4433388c1e0 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 159 | 158 | 5 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 160 | 158 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 160 | 158 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | VE-mono3|VE / Condition, Cell_class and T cell subcluster | 2.73e-04 | 161 | 158 | 5 | 7df3fefc55ab43b897fc78d1f0c7383b10ac33d5 | |
| ToppCell | VE-mono3-|VE / Condition, Cell_class and T cell subcluster | 2.73e-04 | 161 | 158 | 5 | 4e45bf7eceb0ee30dec4d8852778366776ea5a8f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.14e-04 | 166 | 158 | 5 | 9e916fc1858573358e1eb5e3789b2c9f8ef74476 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.23e-04 | 167 | 158 | 5 | 49d9220f22d10ff06c0512c9c40c26ad51728e4f | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-04 | 167 | 158 | 5 | b5d15773be32cd277125fd3b4056a8fefaefa5ec | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.23e-04 | 167 | 158 | 5 | f1ce6e64ebede1f3ef36fe982f46919fd1f814dd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.23e-04 | 167 | 158 | 5 | 7ec032a98a13504d15c7e3a4e259278d07f40180 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.23e-04 | 167 | 158 | 5 | 5e3588eee73693a996bb4846427cf0038ceafbca | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 3.32e-04 | 168 | 158 | 5 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | Ionocyte-iono-1|World / Class top | 3.41e-04 | 169 | 158 | 5 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 169 | 158 | 5 | 8f397cf4f9fd7c6fa88d01a95289ce2a6bc6938d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.51e-04 | 170 | 158 | 5 | 3174ea9cf93892a8b41de10fd4ff6f06bb41502d | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.51e-04 | 170 | 158 | 5 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 3.51e-04 | 170 | 158 | 5 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 171 | 158 | 5 | 6f49537f8d3cf18e65aa999fec32ed347ce2da3e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 171 | 158 | 5 | ab97ae2b127a585f170f028f1c475cdd1b0cdea5 | |
| ToppCell | Influenza_Severe-B_intermediate|World / Disease group and Cell class | 3.60e-04 | 171 | 158 | 5 | 4d33e1dc1efc423dbdd5f4cca6d6440a68add8d0 | |
| Computational | Genes in the cancer module 80. | 6.54e-06 | 32 | 91 | 5 | MODULE_80 | |
| Computational | Genes in the cancer module 51. | 1.19e-05 | 36 | 91 | 5 | MODULE_51 | |
| Computational | Genes in the cancer module 85. | 6.73e-05 | 51 | 91 | 5 | MODULE_85 | |
| Drug | DFC-28 | 2.14e-12 | 14 | 157 | 7 | CID005743054 | |
| Drug | VX-745 | 1.55e-08 | 25 | 157 | 6 | CID003038525 | |
| Drug | ponatinib | 2.22e-08 | 68 | 157 | 8 | ctd:C545373 | |
| Drug | sodium cholate | GP6 PNLIPRP1 CYP3A5 UGT1A10 UGT1A8 SQLE BAAT UGT1A9 PEX12 NDUFS1 ABCC6 CFHR4 MRPS7 NETO1 SLC28A2 SOAT1 | 2.49e-08 | 408 | 157 | 16 | CID000000303 |
| Drug | vandetanib | 2.85e-08 | 99 | 157 | 9 | CID003081361 | |
| Drug | 6-mercaptopurine | 8.68e-07 | 75 | 157 | 7 | CID000667490 | |
| Drug | tritanol | 1.48e-06 | 13 | 157 | 4 | CID000006457 | |
| Drug | sorafenib | 1.57e-06 | 158 | 157 | 9 | CID000216239 | |
| Drug | CI-1033 | 1.72e-06 | 53 | 157 | 6 | CID000156413 | |
| Drug | AC1L9E0Q | 1.81e-06 | 30 | 157 | 5 | CID000443095 | |
| Drug | PCB-61 | 2.06e-06 | 14 | 157 | 4 | CID000036401 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 2.80e-06 | 15 | 157 | 4 | CID000040469 | |
| Drug | glucosiduronate | 3.01e-06 | 171 | 157 | 9 | CID000000610 | |
| Drug | naringenin chalcone | 3.18e-06 | 5 | 157 | 3 | ctd:C027329 | |
| Drug | anthrarobin | 3.18e-06 | 5 | 157 | 3 | ctd:C032186 | |
| Drug | acetaminophen glucuronide | 3.25e-06 | 59 | 157 | 6 | CID000083944 | |
| Drug | estragole | 3.46e-06 | 34 | 157 | 5 | CID000008815 | |
| Drug | 1'-hydroxyestragole | 3.71e-06 | 16 | 157 | 4 | CID000040003 | |
| Drug | anisole | 4.64e-06 | 36 | 157 | 5 | CID000007519 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 4.83e-06 | 17 | 157 | 4 | CID000003573 | |
| Drug | 6beta-hydroxytestosterone | 5.33e-06 | 37 | 157 | 5 | CID000065543 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 6.18e-06 | 18 | 157 | 4 | CID000036614 | |
| Drug | BIRB796 | 6.31e-06 | 66 | 157 | 6 | CID000156422 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 6.34e-06 | 6 | 157 | 3 | ctd:C543211 | |
| Drug | alloin | 6.34e-06 | 6 | 157 | 3 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 6.34e-06 | 6 | 157 | 3 | ctd:C107497 | |
| Drug | capecitabine | 7.87e-06 | 104 | 157 | 7 | CID000060953 | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A | 8.40e-06 | 194 | 157 | 9 | 4524_DN | |
| Drug | imatinib | EPHB3 A2M EPHB4 CYP3A5 PTK2 ITK EPHA2 ROS1 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 | 9.41e-06 | 430 | 157 | 13 | CID000005291 |
| Drug | entacapone | 9.67e-06 | 20 | 157 | 4 | ctd:C071192 | |
| Drug | 2',4'-dihydroxychalcone | 1.10e-05 | 7 | 157 | 3 | ctd:C059354 | |
| Drug | Benzamidoxime hydrochloride | 1.19e-05 | 21 | 157 | 4 | CID000069186 | |
| Drug | anthraflavic acid | 1.28e-05 | 44 | 157 | 5 | CID000006776 | |
| Drug | 3alpha, 7beta-dihydroxy-5beta-cholan-24-oic acid | 1.36e-05 | 206 | 157 | 9 | CID000005645 | |
| Drug | amidoxime | 1.74e-05 | 23 | 157 | 4 | CID000465967 | |
| Drug | 1,4-dihydroxyanthraquinone | 1.76e-05 | 8 | 157 | 3 | ctd:C034890 | |
| Drug | glabridin | 1.76e-05 | 8 | 157 | 3 | ctd:C107601 | |
| Drug | atazanavir | 2.01e-05 | 120 | 157 | 7 | CID000148192 | |
| Drug | glutathione reduced | EPHB4 ABCB7 CYP3A5 GPR37 UGT1A10 UGT1A8 SQLE UGT1A9 OGDH ABCC6 GSTM4 MRPS7 ABCC12 MMP14 | 2.09e-05 | 534 | 157 | 14 | CID000000745 |
| Drug | campestrol | 2.18e-05 | 49 | 157 | 5 | CID000010134 | |
| Drug | AC1L4B0X | 2.24e-05 | 122 | 157 | 7 | CID000153769 | |
| Drug | phenanthroline | 2.41e-05 | 50 | 157 | 5 | CID000067473 | |
| Drug | scopoletin | 2.41e-05 | 50 | 157 | 5 | CID005280460 | |
| Drug | 5-MOP | 2.46e-05 | 25 | 157 | 4 | CID000002355 | |
| Drug | N-acetylbenzidine | 2.46e-05 | 25 | 157 | 4 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 2.46e-05 | 25 | 157 | 4 | CID000006796 | |
| Drug | AC1MRQNQ | 2.62e-05 | 9 | 157 | 3 | CID003522271 | |
| Drug | DHPASiU | 2.62e-05 | 9 | 157 | 3 | CID000197602 | |
| Drug | 3-iodophenol | 2.62e-05 | 9 | 157 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 2.62e-05 | 9 | 157 | 3 | CID000186631 | |
| Drug | Chebi:32663 | 2.62e-05 | 9 | 157 | 3 | CID005460873 | |
| Drug | Thymol | 2.89e-05 | 26 | 157 | 4 | ctd:D013943 | |
| Drug | AC1NQGK1 | 2.93e-05 | 52 | 157 | 5 | CID005195977 | |
| Drug | EKB-569 | 3.11e-05 | 87 | 157 | 6 | CID006445562 | |
| Drug | Scopoletin | 3.37e-05 | 27 | 157 | 4 | ctd:D012603 | |
| Drug | tangeretin | 3.52e-05 | 54 | 157 | 5 | CID000068077 | |
| Drug | Glucuronides | 3.73e-05 | 10 | 157 | 3 | ctd:D020719 | |
| Drug | 2,6-dihydroxyanthraquinone | 3.73e-05 | 10 | 157 | 3 | ctd:C034889 | |
| Drug | CARMINE | 3.92e-05 | 28 | 157 | 4 | CID000014749 | |
| Drug | erucin | 3.92e-05 | 28 | 157 | 4 | CID000078160 | |
| Drug | tetrabromobisphenol A | EPHB3 BOC AMER1 MYO7B PPP1R15A TXNIP KLHDC1 FAM171A2 NFATC4 LIPG EPHA2 EGFLAM PLEKHH2 ZSWIM4 SNTB1 SOAT1 EPHA4 TECPR1 | 4.48e-05 | 891 | 157 | 18 | ctd:C020806 |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 4.52e-05 | 29 | 157 | 4 | CID005375667 | |
| Drug | trans-3'-hydroxycotinine | 4.52e-05 | 29 | 157 | 4 | CID000000414 | |
| Drug | oltipraz | 4.71e-05 | 137 | 157 | 7 | CID000047318 | |
| Drug | Z 338 | 4.72e-05 | 2 | 157 | 2 | ctd:C410959 | |
| Drug | 7-vinyloxycoumarin | 4.72e-05 | 2 | 157 | 2 | CID000129300 | |
| Drug | 4-nitrophenyl)imidazole | 5.10e-05 | 11 | 157 | 3 | CID000123155 | |
| Drug | AC1O5XMV | 5.10e-05 | 11 | 157 | 3 | CID006442661 | |
| Drug | NBTGR | 5.10e-05 | 11 | 157 | 3 | CID000096048 | |
| Drug | TCPOBOP | 5.12e-05 | 95 | 157 | 6 | CID000005382 | |
| Drug | DNCB | 5.18e-05 | 189 | 157 | 8 | CID000000006 | |
| Drug | dihydroartemisinin | 5.19e-05 | 30 | 157 | 4 | CID000107770 | |
| Drug | urochloralic acid | 5.42e-05 | 59 | 157 | 5 | CID003036914 | |
| Drug | SN-38G | 5.42e-05 | 59 | 157 | 5 | CID000443154 | |
| Drug | PCB 156 | 5.92e-05 | 31 | 157 | 4 | CID000038019 | |
| Drug | 4'-HPPH | 5.92e-05 | 31 | 157 | 4 | CID000017732 | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; HL60; HT_HG-U133A | 6.22e-05 | 194 | 157 | 8 | 2472_DN | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 6.45e-05 | 195 | 157 | 8 | 3278_UP | |
| Drug | NNAL | 6.73e-05 | 32 | 157 | 4 | CID000104856 | |
| Drug | N-OH-DABZ | 6.76e-05 | 12 | 157 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 6.76e-05 | 12 | 157 | 3 | CID000088735 | |
| Drug | 4-hydroxyestrone | 6.76e-05 | 12 | 157 | 3 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 6.76e-05 | 12 | 157 | 3 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 6.76e-05 | 12 | 157 | 3 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 6.76e-05 | 12 | 157 | 3 | CID000276709 | |
| Drug | BP-3,6-quinol | 7.62e-05 | 33 | 157 | 4 | CID000119292 | |
| Drug | 2-hydroxyestrone | 8.74e-05 | 13 | 157 | 3 | ctd:C024980 | |
| Drug | tryptophan-leucine | 8.74e-05 | 13 | 157 | 3 | CID000323786 | |
| Drug | 5-azido-UDP-glucuronic acid | 8.74e-05 | 13 | 157 | 3 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 8.74e-05 | 13 | 157 | 3 | CID000000411 | |
| Drug | alizarin | 8.74e-05 | 13 | 157 | 3 | ctd:C010078 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 9.65e-05 | 35 | 157 | 4 | CID010436171 | |
| Drug | fluconazole | 9.95e-05 | 107 | 157 | 6 | CID000003365 | |
| Drug | pregnenolone-16 alpha-carbonitrile | 1.00e-04 | 67 | 157 | 5 | CID000015032 | |
| Drug | Cocaine | EPHB3 EPHB4 TUT4 MYO5A UGT1A8 RPS9 OBSCN PPP1R15A NEB PTK2 ITPR1 PSME4 EPHA2 PURB SLC17A8 MMP14 EPHA3 EPHA4 EPHA5 EPHA8 EPHB1 LARGE1 | 1.02e-04 | 1314 | 157 | 22 | ctd:D003042 |
| Drug | glucoraphanin | 1.08e-04 | 36 | 157 | 4 | CID000656556 | |
| Drug | bevirimat | 1.08e-04 | 36 | 157 | 4 | CID000457928 | |
| Drug | propranolol glucuronide | 1.11e-04 | 14 | 157 | 3 | CID000119515 | |
| Drug | 2-naphthylamine | 1.16e-04 | 110 | 157 | 6 | CID000007057 | |
| Drug | erythromycin stearate | 1.22e-04 | 111 | 157 | 6 | CID000012559 | |
| Disease | Gastric Adenocarcinoma | 1.36e-07 | 45 | 156 | 6 | C0278701 | |
| Disease | indole-3-carboxylate measurement | 1.45e-07 | 3 | 156 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 1.45e-07 | 3 | 156 | 3 | EFO_0022216 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 1.44e-06 | 5 | 156 | 3 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 1.44e-06 | 5 | 156 | 3 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 1.44e-06 | 5 | 156 | 3 | EFO_0801853 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 2.87e-06 | 6 | 156 | 3 | EFO_0800566 | |
| Disease | X-21339 measurement | 5.00e-06 | 7 | 156 | 3 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 7.96e-06 | 8 | 156 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 7.96e-06 | 8 | 156 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 7.96e-06 | 8 | 156 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 7.96e-06 | 8 | 156 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 7.96e-06 | 8 | 156 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 7.96e-06 | 8 | 156 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 7.96e-06 | 8 | 156 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 7.96e-06 | 8 | 156 | 3 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 7.96e-06 | 8 | 156 | 3 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 7.96e-06 | 8 | 156 | 3 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 7.96e-06 | 8 | 156 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 7.96e-06 | 8 | 156 | 3 | EFO_0800766 | |
| Disease | Metastatic melanoma | 9.94e-06 | 54 | 156 | 5 | C0278883 | |
| Disease | X-11442 measurement | 1.19e-05 | 9 | 156 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.19e-05 | 9 | 156 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.19e-05 | 9 | 156 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.19e-05 | 9 | 156 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.19e-05 | 9 | 156 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.19e-05 | 9 | 156 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.19e-05 | 9 | 156 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.19e-05 | 9 | 156 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.19e-05 | 9 | 156 | 3 | EFO_0004570, GO_0009410 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.39e-05 | 28 | 156 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | bilirubin measurement, response to tenofovir | 1.69e-05 | 10 | 156 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | indoleacetate measurement | 1.69e-05 | 10 | 156 | 3 | EFO_0021015 | |
| Disease | X-21448 measurement | 1.69e-05 | 10 | 156 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.69e-05 | 10 | 156 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 1.69e-05 | 10 | 156 | 3 | EFO_0800867 | |
| Disease | pregnenetriol sulfate measurement | 2.32e-05 | 11 | 156 | 3 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 2.32e-05 | 11 | 156 | 3 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 2.32e-05 | 11 | 156 | 3 | EFO_0800972 | |
| Disease | X-21796 measurement | 2.32e-05 | 11 | 156 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 2.32e-05 | 11 | 156 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 2.32e-05 | 11 | 156 | 3 | EFO_0010219 | |
| Disease | Hypoxic Brain Damage | 2.78e-05 | 2 | 156 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 2.78e-05 | 2 | 156 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 2.78e-05 | 2 | 156 | 2 | C1527348 | |
| Disease | Anoxia of brain | 2.78e-05 | 2 | 156 | 2 | C0995195 | |
| Disease | p-cresol glucuronide measurement | 3.08e-05 | 12 | 156 | 3 | EFO_0800079 | |
| Disease | biliverdin measurement | 3.08e-05 | 12 | 156 | 3 | EFO_0021033 | |
| Disease | pregnenetriol disulfate measurement | 3.99e-05 | 13 | 156 | 3 | EFO_0800587 | |
| Disease | X-24588 measurement | 3.99e-05 | 13 | 156 | 3 | EFO_0800898 | |
| Disease | retinol dehydrogenase 16 measurement | 3.99e-05 | 13 | 156 | 3 | EFO_0802007 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 9.33e-05 | 17 | 156 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | X-21441 measurement | 9.33e-05 | 17 | 156 | 3 | EFO_0800814 | |
| Disease | serum gamma-glutamyl transferase measurement | PDE4C UGT1A10 UGT1A8 BAZ1B UGT1A9 TWNK SLC28A3 ITK ITPR1 PTPRM EPHA2 NBEAL2 PURB SLC17A8 EPHB1 | 1.08e-04 | 914 | 156 | 15 | EFO_0004532 |
| Disease | angiopoietin-related protein 1 measurement | 1.12e-04 | 18 | 156 | 3 | EFO_0801382 | |
| Disease | tissue factor measurement | 1.80e-04 | 21 | 156 | 3 | EFO_0010623 | |
| Disease | inactive pancreatic lipase-related protein 1 measurement | 2.75e-04 | 5 | 156 | 2 | EFO_0801693 | |
| Disease | complement C1s subcomponent measurement | 4.11e-04 | 6 | 156 | 2 | EFO_0008091 | |
| Disease | renal cell carcinoma (implicated_via_orthology) | 4.11e-04 | 6 | 156 | 2 | DOID:4450 (implicated_via_orthology) | |
| Disease | xanthurenate measurement | 4.79e-04 | 29 | 156 | 3 | EFO_0010551 | |
| Disease | BMI-adjusted waist-hip ratio, physical activity measurement | 4.97e-04 | 69 | 156 | 4 | EFO_0007788, EFO_0008002 | |
| Disease | response to dolutegravir | 5.30e-04 | 30 | 156 | 3 | EFO_0600017 | |
| Disease | temporal horn of lateral ventricle volume measurement | 5.85e-04 | 72 | 156 | 4 | EFO_0010333 | |
| Disease | Large cell carcinoma of lung | 6.42e-04 | 32 | 156 | 3 | C0345958 | |
| Disease | Squamous cell carcinoma of lung | 6.42e-04 | 32 | 156 | 3 | C0149782 | |
| Disease | hepatitis A virus cellular receptor 2 measurement | 7.62e-04 | 8 | 156 | 2 | EFO_0008151 | |
| Disease | metabolite measurement | CYP3A5 UGT1A10 UGT1A8 BAAT UGT1A9 ZRANB3 ITPR2 PLEKHH2 PNP EPHB1 | 8.28e-04 | 560 | 156 | 10 | EFO_0004725 |
| Disease | symmetrical dimethylarginine measurement | 9.76e-04 | 9 | 156 | 2 | EFO_0006523 | |
| Disease | Neuronal ceroid lipofuscinosis | 9.76e-04 | 9 | 156 | 2 | cv:C0027877 | |
| Disease | neural tube defect (implicated_via_orthology) | 9.76e-04 | 9 | 156 | 2 | DOID:0080074 (implicated_via_orthology) | |
| Disease | vitamin D deficiency | 9.87e-04 | 37 | 156 | 3 | EFO_0003762 | |
| Disease | thyroxine measurement | 9.99e-04 | 83 | 156 | 4 | EFO_0005130 | |
| Disease | cholelithiasis | 1.24e-03 | 88 | 156 | 4 | EFO_0004799 | |
| Disease | Drug-Induced Liver Disease | 1.44e-03 | 404 | 156 | 8 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 1.44e-03 | 404 | 156 | 8 | C3658290 | |
| Disease | Hepatitis, Toxic | 1.44e-03 | 404 | 156 | 8 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 1.44e-03 | 404 | 156 | 8 | C4279912 | |
| Disease | Chemical and Drug Induced Liver Injury | 1.44e-03 | 404 | 156 | 8 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 1.44e-03 | 404 | 156 | 8 | C1262760 | |
| Disease | urate measurement, bone density | UGT1A10 UGT1A8 UGT1A9 OGDH ITPR1 ITPR2 CCER1 SLC17A8 DHX35 EPHB1 | 1.75e-03 | 619 | 156 | 10 | EFO_0003923, EFO_0004531 |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.77e-03 | 12 | 156 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | dodecanedioate measurement | 1.77e-03 | 12 | 156 | 2 | EFO_0021054 | |
| Disease | alcoholic pancreatitis | 1.85e-03 | 98 | 156 | 4 | EFO_1002013 | |
| Disease | Gastrointestinal Stromal Sarcoma | 1.98e-03 | 47 | 156 | 3 | C3179349 | |
| Disease | coronary artery disease (is_implicated_in) | 1.99e-03 | 100 | 156 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | vitamin D measurement, COVID-19 | 2.23e-03 | 49 | 156 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | Gastrointestinal Stromal Tumors | 2.37e-03 | 50 | 156 | 3 | C0238198 | |
| Disease | tumor necrosis factor beta measurement | 2.79e-03 | 15 | 156 | 2 | EFO_0008308 | |
| Disease | pathological myopia | 2.90e-03 | 111 | 156 | 4 | EFO_0004207 | |
| Disease | pancreatitis | 3.17e-03 | 16 | 156 | 2 | EFO_0000278 | |
| Disease | protein C measurement | 3.59e-03 | 17 | 156 | 2 | EFO_0004633 | |
| Disease | response to cyclophosphamide | 3.59e-03 | 17 | 156 | 2 | GO_1902518 | |
| Disease | urate measurement, spine bone mineral density | 3.61e-03 | 58 | 156 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | acute lymphoblastic leukemia | 5.20e-03 | 66 | 156 | 3 | EFO_0000220 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TTPAVYARVAKLIPW | 241 | Q6GPI1 | |
| PYVRVYLLPERKWAC | 791 | A0FGR9 | |
| QDVRRKVPWYPSDFL | 391 | Q96Q91 | |
| APKASLTLERWYVAP | 121 | Q14032 | |
| QFRESLRSYAATPWP | 611 | Q63HQ2 | |
| VEVRWYRSEPSTPVF | 61 | Q9UIR0 | |
| FAALTTFWYATRPKP | 36 | P33121 | |
| KYWTEPEEFRPERFS | 406 | P20815 | |
| VKYRFSWPFREPVTR | 1356 | Q9UIG0 | |
| PIRWTAPEAIAFRKF | 841 | P54756 | |
| SEPDWRDFRPLEKRY | 691 | Q5JTC6 | |
| RYQTFRFIWLTKPPG | 6 | P0C7M7 | |
| VSTLPRPVKLYEWRE | 166 | Q8TC90 | |
| LVPRPDYASRYVLWK | 701 | Q86XH1 | |
| PWAPRSYLEKVVAIY | 446 | Q9NYB9 | |
| PHTETVRKYFPETWI | 726 | P01023 | |
| AYKFVTQWRRPLPAR | 791 | Q9BYT9 | |
| LVVAYPYDLVRSPWK | 521 | Q8N436 | |
| DVYRDWTPPSKELLR | 611 | Q149M9 | |
| WESATPLRFREVPYA | 151 | P50281 | |
| DCKWYIRAPPRSKIY | 201 | Q8TDF5 | |
| DRVIASFPKWYTPEA | 81 | O95755 | |
| VPVRYARLWTEIPTK | 796 | Q14571 | |
| SPIFGLWSNYRPRKE | 91 | Q8NHS3 | |
| LWSNYRPRKEPLIVS | 96 | Q8NHS3 | |
| GRKRDFSPVPWSQYF | 36 | Q9Y570 | |
| AVFPRPWSAVRVKEY | 381 | Q6ZNF0 | |
| TKAPPFVARETLRAW | 206 | Q9Y2S7 | |
| IPVRWTAPEAIAYRK | 786 | P54762 | |
| VEWSSRGPPNKRFYE | 316 | Q8N543 | |
| DVRPIFWASRPKSYI | 361 | P42898 | |
| PTNFAKWRTATTPYR | 636 | O95461 | |
| NRDTDSPYPLWRLKT | 436 | Q9H2X6 | |
| KIPIRWTAPEAIAFR | 781 | P54760 | |
| MRPPFTYATLIRWAI | 336 | Q9BZS1 | |
| PVKYARLWSEIPSEI | 801 | Q14643 | |
| TTSWIDPRDRYTKPL | 31 | Q8IX03 | |
| KYLFAVRWSPVRPLV | 436 | Q96EX3 | |
| IPIRWTAPEAIAYRK | 786 | P54764 | |
| NPERWYRASFPIITV | 156 | Q9HCN6 | |
| PWSPEKIGTRFLLYT | 46 | P54315 | |
| REWYQSKIPRSPSDL | 631 | Q08493 | |
| FRKILQWPPIYTAAR | 81 | P35663 | |
| LWKEFRSYLSQPRNP | 426 | Q9Y5X9 | |
| TRWGYTDFPKVVNRP | 71 | Q8N4P6 | |
| PIRWTAPEAIAYRKF | 801 | P54753 | |
| RYLRPARSLVFPWFS | 196 | Q96RR1 | |
| AAGYFRVWKVPKPRR | 116 | Q75WM6 | |
| YDRRADKPWTKLTPA | 656 | Q8IZ21 | |
| VRIYLTVARKWPFFG | 1336 | Q8IVE3 | |
| FRRPVWPAVVYAFTI | 281 | Q9Y5I0 | |
| RPTPWNLRAYSSRYK | 116 | Q7RTY9 | |
| SVPWRVDKLPLYASV | 106 | A8MVW0 | |
| WVSPAYLDRRLKLSP | 5656 | Q5VST9 | |
| TPWKLFLRKEVFYPR | 1241 | Q96JP2 | |
| PRLRTTISRAKPVWY | 971 | Q02218 | |
| TISRAKPVWYAGRDP | 976 | Q02218 | |
| TYADKYTQTPWRRIP | 761 | Q9H7U1 | |
| RLDPWERIIPTFKYN | 2046 | Q9C0G6 | |
| KSKPFVAPRWATRVF | 1236 | Q9P2D3 | |
| VPDPTKYFVTRWSTD | 746 | Q8NB78 | |
| KTVPGASDLFYWPRR | 171 | O15354 | |
| PRTSKTDSYELVWRP | 481 | Q9BWV1 | |
| VTSKIRLPAQPSWYV | 731 | Q8WTW3 | |
| IPLTPREFEKLWARY | 881 | Q5THR3 | |
| ASVLYAEKPPRWVIY | 641 | Q9H5Z1 | |
| IRWTAPEAISYRKFT | 781 | P29317 | |
| SFQWRIRNLPYPKDV | 101 | Q9BVM2 | |
| PIRWTAPEAIAFRTF | 801 | P29322 | |
| PVAEWAVPQSSRLKY | 211 | Q15811 | |
| VYFCFKSEPWITKPR | 531 | Q14534 | |
| LPREKYLTWASRQEP | 271 | P01876 | |
| KWSRVPFSVPDFDFL | 651 | Q96C10 | |
| ARKPLRFYVRGSPWV | 271 | P29372 | |
| YSAEEEPRVAPTKVW | 806 | Q02246 | |
| IPIRWTSPEAIAYRK | 786 | P29320 | |
| DTTSFPQKVYLPWSR | 221 | Q92496 | |
| KPVRRFVPDSWKNFF | 76 | Q8N4S9 | |
| VTEFAWVLAPRPKRA | 36 | Q96LL3 | |
| RPSLPRFISTYSWAD | 416 | Q12912 | |
| DIETRSWTKFPNIPY | 196 | Q8IYD2 | |
| PTPRDKLSCWVYKDR | 121 | Q8N7A1 | |
| FLEPWASAAVKRRPR | 16 | P20849 | |
| WPLPEYRKSKRGSSF | 401 | Q9UKT8 | |
| FYSERPQIPFVWKRP | 56 | O14815 | |
| PSFLRVPKWIIALYT | 296 | Q96LJ7 | |
| RTTYFLTIPDPWDSR | 136 | P60507 | |
| RWPTDSYPVGKLRIF | 161 | P60507 | |
| YERPIAFTSRSKKLW | 886 | Q9NQ36 | |
| YPLWKVTFPVRVFHL | 91 | P00491 | |
| SPSKWFWKLVPARYR | 216 | Q08AD1 | |
| NYRKTFDVIVIDPPW | 276 | Q8N3J2 | |
| KPSYRNAITVPFKAW | 251 | Q96QR8 | |
| STPPASAFLKAWVYR | 421 | O75807 | |
| WPMYRDTPVSKRSFL | 1351 | P28827 | |
| PVKWASPEVFSFSRY | 521 | Q08881 | |
| KYPFWPAVVKSVRQR | 421 | Q2TAK8 | |
| SWVCRKTYVTPRRPF | 6 | P46781 | |
| QVRWSRYSPEFKDPL | 31 | Q9Y2R9 | |
| RRKEAWFSPVHTYPL | 361 | Q13884 | |
| WRKGTYFDAIITDPP | 296 | Q7Z4G4 | |
| TFTEKLWPLFYPGIR | 486 | Q9HCM9 | |
| KNPTFLDYVRPRSWT | 531 | P35610 | |
| DYLAVPSPLAWSKAR | 376 | Q14934 | |
| WDVVRSPISFFERTP | 1026 | O95255 | |
| LTSKPYAFTARPWET | 231 | P28331 | |
| QKYPFWPAVIKSIRR | 401 | Q5H9M0 | |
| HPVRLFWPKSRSFDY | 96 | Q0D2K3 | |
| TKCWAYDPSRRPRFT | 656 | Q05397 | |
| KRYFTWDPSRFPQPR | 436 | Q14697 | |
| SRFLPKPLYTRVAVW | 201 | Q03013 | |
| DTPIPRWKLSSAETY | 1821 | Q6ZNJ1 | |
| FWRPPVRTLTFEDFT | 321 | Q96SF7 | |
| EESAVPKRSWRLRPY | 161 | Q5JXC2 | |
| RRKAVESWNPVPYSV | 721 | Q8TE76 | |
| KESTLPPRTYWKEAR | 1161 | Q9Y520 | |
| KWIPFSYTYRRPLRT | 46 | Q8NDV1 | |
| EPWSSFDIYTRKGPL | 266 | Q9H5Q4 | |
| RISAFPDPFIRWSKD | 76 | A0A087WV53 | |
| PLIYKAVPSWFVRVE | 406 | P41252 | |
| LFSKYPTRVYWRPVL | 216 | Q9HAS3 | |
| DEYSIHPPSSRWKRF | 141 | O00623 | |
| PKDWPSRGEITFRDY | 1111 | Q96J65 | |
| GPSTYQRRSRWPFSK | 51 | O43868 | |
| RYPVPSEWVKNFRRE | 731 | Q8WXE9 | |
| SYVWPKDRPDLRARV | 126 | O75027 | |
| VSKVWPTFFERPLVR | 76 | C9JRZ8 | |
| RHWPVPYKRFDFRPK | 51 | O75503 | |
| SPLRIWSKFYRSDPR | 56 | Q5SQS8 | |
| LRPTKAPGFVYAWLE | 2026 | A5YKK6 | |
| FVSRLWLTYRRDFPP | 116 | Q86TL0 | |
| YISYPRRRMFWETSP | 191 | Q6P3X8 | |
| WIPTRHLKFYNEPIR | 846 | P63136 | |
| SRKLYNWLRVAPYRP | 746 | Q7KZ85 | |
| TRITDRALYWKPAPR | 206 | Q96ET8 | |
| WLLRTDFVLDYPKPV | 251 | Q9HAW8 | |
| FERALLKWTEYTPDP | 446 | Q969N2 | |
| ETYPWRPSFTLDFKT | 296 | Q9Y458 | |
| TEYPDVAWPLRFRIL | 111 | O43353 | |
| FALYTPERTRQRWPV | 681 | Q7Z6L1 | |
| PGVYTRLPLFRDWIK | 836 | Q9Y5Y6 | |
| VPYTRVWDFIPDNSK | 61 | Q86V40 | |
| KPLHPFTEYIFRVVW | 156 | P08922 | |
| WLLRTDFVLDYPKPV | 251 | O60656 | |
| LQRFSVWYTPLAKRP | 536 | Q9P2J2 | |
| DWDPYVPKIFTRILR | 271 | Q14997 | |
| HTYIKVFVPSWRKDP | 126 | A2A288 | |
| VQRKYWTSKPEPSTR | 351 | O95361 | |
| APRIKKFAIYRWDPD | 36 | P21912 | |
| VDYWVKAFLDRPSQP | 121 | Q9H3M7 | |
| PVFIPLVLAFRYWAK | 491 | Q5TAX3 | |
| AAREKPRRWTPYPSQ | 341 | Q9H2Y7 | |
| RPLDYTFVPRTWIFP | 121 | Q6ZT98 | |
| HRPTPLTIWAFYKEL | 106 | P0DTE5 | |
| NPTDIYPSKWIARLR | 1731 | P49815 | |
| PWKRFFTSLPVYAII | 306 | Q8NDX2 | |
| RPFYPDWKTRPEVKS | 81 | Q8TF47 | |
| WLLRTDFVLDYPKPV | 251 | Q9HAW9 | |
| VPSSLRYPWTEEIEK | 86 | Q5FWF4 | |
| EPVQKRIVFWSFPRS | 61 | Q9H7M6 | |
| QRKYWTSKPEPSTRE | 136 | Q309B1 | |
| LYTKFARVWIPDPEE | 6 | Q9Y4I1 | |
| YRTKPPDRWASLVTA | 1361 | Q6PIF6 | |
| PDTPILIRAKRAYWN | 5246 | P20929 |